Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 136.26 USD | +0.26% |
|
-2.84% | +56.01% |
| Market Cap | 8.89B 7.98B 7.35B 6.68B 12.63B 834B 12.99B 88.01B 35.07B 447B 33.38B 32.67B 1,412B | P/E 2026 * |
26.8x | P/E 2027 * | 494x |
|---|---|---|---|---|---|
| Enterprise Value | 8.32B 7.46B 6.87B 6.24B 11.82B 780B 12.15B 82.31B 32.79B 418B 31.21B 30.55B 1,321B | EV / Sales 2026 * |
14.7x | EV / Sales 2027 * | 34.7x |
| Free-Float |
96.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +0.26% | ||
| 1 week | -2.84% | ||
| Current month | -5.93% | ||
| 1 month | -5.20% | ||
| 3 months | -9.16% | ||
| 6 months | +37.14% | ||
| Current year | +56.01% |
| 1 week | 128 |  | 143.3 |
| 1 month | 126.39 | | 152.18 |
| Current year | 77 | | 160.81 |
| 1 year | 77 | | 160.81 |
| 3 years | 15.05 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 68 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 175,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | -2.84% | +63.72% | +779.66% | 8.87B | |
| +0.01% | +11.10% | +60.83% | +70.43% | 68.22B | |
| +1.22% | +9.56% | +15.97% | +90.23% | 59.82B | |
| +0.24% | +1.35% | +23.78% | +97.55% | 56.07B | |
| +1.60% | +19.44% | +28.80% | +112.95% | 47.67B | |
| -1.32% | +4.78% | +29.15% | +40.40% | 45.95B | |
| -3.54% | -0.60% | +207.76% | +879.50% | 43.29B | |
| -3.33% | +6.90% | +22.78% | +48.07% | 35.66B | |
| -2.19% | -3.71% | +90.94% | +66.33% | 34.73B | |
| +2.92% | +14.41% | -37.74% | +403.12% | 25.47B | |
| Average | -0.41% | +4.63% | +50.60% | +258.82% | 43B | |
| Weighted average by Cap. | -0.40% | +5.33% | +51.01% | +193.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 567M 509M 469M 426M 806M 53.18B 828M 5.61B 2.24B 28.49B 2.13B 2.08B 90.07B | 240M 215M 199M 180M 341M 22.53B 351M 2.38B 947M 12.07B 902M 883M 38.15B |
| Net income | 354M 317M 292M 265M 502M 33.15B 516M 3.5B 1.39B 17.76B 1.33B 1.3B 56.14B | 42.68M 38.28M 35.28M 32.04M 60.63M 4B 62.33M 422M 168M 2.14B 160M 157M 6.78B |
| Net Debt | -576M -517M -476M -433M -819M -54.03B -841M -5.7B -2.27B -28.95B -2.16B -2.12B -91.51B | -567M -509M -469M -426M -806M -53.18B -828M -5.61B -2.24B -28.49B -2.13B -2.08B -90.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | US$136.26 | +0.26% | 528,488 |
| 09/11/26 | US$135.90 | +2.92% | 607,111 |
| 06/11/26 | US$132.04 | -2.38% | 972,945 |
| 05/11/26 | US$135.26 | -5.66% | 584,678 |
| 04/11/26 | US$143.37 | +2.23% | 777,232 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
